{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:08:10Z","timestamp":1768442890258,"version":"3.49.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T00:00:00Z","timestamp":1413244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1038\/nrclinonc.2014.169","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T10:22:04Z","timestamp":1413282124000},"page":"723-731","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Management of familial cancer: sequencing, surveillance and society"],"prefix":"10.1038","volume":"11","author":[{"given":"Nardin","family":"Samuel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Villani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad V.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Malkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,14]]},"reference":[{"key":"BFnrclinonc2014169_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrg2841","volume":"11","author":"M Meyerson","year":"2010","unstructured":"Meyerson, M., Gabriel, S. & Getz, G. Advances in understanding cancer genomes through second-generation sequencing. Nat. Rev. Genet. 11, 685\u2013696 (2010).","journal-title":"Nat. Rev. Genet."},{"key":"BFnrclinonc2014169_CR2","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/pbc.24555","volume":"60","author":"JD Schiffman","year":"2013","unstructured":"Schiffman, J. D.  et al. Update on pediatric cancer predisposition syndromes. Pediatr. Blood Cancer 60, 1247\u20131252 (2013).","journal-title":"Pediatr. Blood Cancer"},{"key":"BFnrclinonc2014169_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.ejca.2013.12.005","volume":"50","author":"D Bakry","year":"2014","unstructured":"Bakry, D.  et al. Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium. Eur. J. Cancer 50, 987\u2013996 (2014).","journal-title":"Eur. J. Cancer"},{"key":"BFnrclinonc2014169_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/jmedgenet-2013-102238","volume":"51","author":"HF Vasen","year":"2014","unstructured":"Vasen, H. F.  et al. Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium \u201cCare for CMMR-D\u201d (C4CMMR-D). J. Med. Genet. 51, 283\u2013293 (2014).","journal-title":"J. Med. Genet."},{"key":"BFnrclinonc2014169_CR5","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1126\/science.1174334","volume":"325","author":"DA Hill","year":"2009","unstructured":"Hill, D. A.  et al. DICER1 mutations in familial pleuropulmonary blastoma. Science 325, 965 (2009).","journal-title":"Science"},{"key":"BFnrclinonc2014169_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.molmed.2012.07.003","volume":"18","author":"CS Choong","year":"2012","unstructured":"Choong, C. S., Priest, J. R. & Foulkes, W. D. Exploring the endocrine manifestations of DICER1 mutations. Trends Mol. Med. 18, 503\u2013505 (2012).","journal-title":"Trends Mol. Med."},{"key":"BFnrclinonc2014169_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00401-014-1318-7","volume":"128","author":"L de Kock","year":"2014","unstructured":"de Kock, L.  et al. Germ-line and somatic DICER1 mutations in pineoblastoma. Acta Neuropathol. 128, 583\u2013595 (2014).","journal-title":"Acta Neuropathol."},{"key":"BFnrclinonc2014169_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/138920210791616734","volume":"5","author":"SM Rothenberg","year":"2010","unstructured":"Rothenberg, S. M. & Settleman, J. Discovering tumor suppressor genes through genome wide copy number analysis. Curr. Genomics 5, 297\u2013310 (2010).","journal-title":"Curr. Genomics"},{"key":"BFnrclinonc2014169_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.semradonc.2007.10.005","volume":"18","author":"JL Costa","year":"2008","unstructured":"Costa, J. L., Meijer, G., Ylstra, B. & Caldas, C. Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies. Semin. Radiat. Oncol. 18, 98\u2013104 (2008).","journal-title":"Semin. Radiat. Oncol."},{"key":"BFnrclinonc2014169_CR10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ng.861","volume":"43","author":"I Comino-Mendez","year":"2011","unstructured":"Comino-Mendez, I.  et al. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat. Genet. 43, 663\u2013667 (2011).","journal-title":"Nat. Genet."},{"key":"BFnrclinonc2014169_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ng.2552","volume":"45","author":"MJ Smith","year":"2013","unstructured":"Smith, M. J.  et al. Loss of function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas. Nat. Genet. 45, 295\u2013298 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrclinonc2014169_CR12","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/ng.2754","volume":"45","author":"S Shah","year":"2013","unstructured":"Shah, S.  et al. A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nat. Genet. 45, 1226\u20131231 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrclinonc2014169_CR13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1200\/JCO.2013.49.7271","volume":"32","author":"ZK Stadler","year":"2014","unstructured":"Stadler, Z. K., Schrader, K. A., Vijai, J., Robson, M. E. & Offit, K. Cancer genomics and inherited risk. J. Clin. Oncol. 32, 687\u2013698 (2014).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2014169_CR14","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nrc3130","volume":"11","author":"SB Baylin","year":"2011","unstructured":"Baylin, S. B. & Jones, P. A. A decade of exploring the cancer epigenome\u2014biological and translational implications. Nat. Rev. Cancer 11, 726\u2013734 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnrclinonc2014169_CR15","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1158\/1078-0432.CCR-11-1921","volume":"18","author":"ER Lawlor","year":"2012","unstructured":"Lawlor, E. R. & Theiele, C. J. Epigenetic changes in pediatric solid tumors: promising new targets. Clin. Cancer Res. 18, 2768\u20132779 (2012).","journal-title":"Clin. Cancer Res."},{"key":"BFnrclinonc2014169_CR16","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1158\/2159-8290.CD-13-0092","volume":"3","author":"JK Killian","year":"2013","unstructured":"Killian, J. K.  et al. Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov. 3, 648\u2013657 (2013).","journal-title":"Cancer Discov."},{"key":"BFnrclinonc2014169_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ajmg.c.31363","volume":"163C","author":"S Choufani","year":"2013","unstructured":"Choufani, S., Shuman, C. & Weksberg, R. Molecular findings in Beckwith\u2013Wiedemann syndrome. Am. J. Med. Genet. C. Sem. Med. Genet. 163C, 131\u2013140 (2013).","journal-title":"Am. J. Med. Genet. C. Sem. Med. Genet."},{"key":"BFnrclinonc2014169_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev-anchem-062012-092628","volume":"6","author":"ER Mardis","year":"2013","unstructured":"Mardis, E. R. Next-generation sequencing platforms. Annu. Rev. Anal. Chem. (Palo Alto Calif.) 6, 287\u2013303 (2013).","journal-title":"Annu. Rev. Anal. Chem. (Palo Alto Calif.)"},{"key":"BFnrclinonc2014169_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1586\/erm.13.1","volume":"13","author":"SF Idris","year":"2013","unstructured":"Idris, S. F., Ahmad, S. S., Scott, M. A., Vassiliou, G. S. & Hadfield, J. The role of high-throughput technologies in clinical cancer genomics. Expert Rev. Mol. Diagn. 13, 167\u2013181 (2013).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"BFnrclinonc2014169_CR20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature12981","volume":"505","author":"N Rahman","year":"2014","unstructured":"Rahman, N. Realizing the promise of cancer predisposition genes. Nature 505, 302\u2013308 (2014).","journal-title":"Nature"},{"key":"BFnrclinonc2014169_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng879","volume":"31","author":"H Meijers-Heijboer","year":"2002","unstructured":"Meijers-Heijboer, H.  et al. Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet. 31, 55\u201359 (2002).","journal-title":"Nat. Genet."},{"key":"BFnrclinonc2014169_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nbt.2895","volume":"32","author":"H Hu","year":"2014","unstructured":"Hu, H.  et al. A unified test of linkage analysis and rare variant association for analysis of pedigree sequence data. Nat. Biotechnol. 32, 663\u2013669 (2014).","journal-title":"Nat. Biotechnol."},{"key":"BFnrclinonc2014169_CR23","doi-asserted-by":"publisher","first-page":"13481","DOI":"10.1073\/pnas.1304227110","volume":"110","author":"JJ Gartner","year":"2013","unstructured":"Gartner, J. J.  et al. Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma. Proc. Natl Acad. Sci. USA 110, 13481\u201313486 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrclinonc2014169_CR24","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/nbt.2422","volume":"30","author":"LD Ward","year":"2012","unstructured":"Ward, L. D. & Kellis, M. Interpreting noncoding genetic variation in complex human traits and human disease. Nat. Biotechnol. 30, 1095\u20131106 (2012).","journal-title":"Nat. Biotechnol."},{"key":"BFnrclinonc2014169_CR25","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/hmg\/ddr525","volume":"21","author":"C Turnbull","year":"2012","unstructured":"Turnbull, C.  et al. Gene\u2013gene interactions in breast cancer susceptibility. Hum. Mol. Genet. 21, 958\u2013962 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrclinonc2014169_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10549-010-0842-y","volume":"124","author":"PG Moorman","year":"2010","unstructured":"Moorman, P. G.  et al. Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis. Breast Cancer Res. Treat. 124, 441\u2013451 (2010).","journal-title":"Breast Cancer Res. Treat."},{"key":"BFnrclinonc2014169_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1373\/clinchem.2012.184580","volume":"59","author":"N Samuel","year":"2013","unstructured":"Samuel, N. & Hudson, T. J. Translating genomics to the clinic: implications of cancer heterogeneity. Clin. Chem. 59, 127\u2013137 (2013).","journal-title":"Clin. Chem."},{"key":"BFnrclinonc2014169_CR28","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1056\/NEJMoa1205119","volume":"367","author":"Z Zhuang","year":"2012","unstructured":"Zhuang, Z.  et al. Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. N. Engl. J. Med. 367, 922\u2013930 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrclinonc2014169_CR29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.18632\/oncotarget.468","volume":"3","author":"RH Scott","year":"2012","unstructured":"Scott, R. H.  et al. Stratification of Wilms tumor by genetic and epigenetic analysis. Oncotarget 3, 327\u2013335 (2012).","journal-title":"Oncotarget"},{"key":"BFnrclinonc2014169_CR30","doi-asserted-by":"publisher","first-page":"e96531","DOI":"10.1371\/journal.pone.0096531","volume":"9","author":"S Behjati","year":"2014","unstructured":"Behjati, S.  et al. A pathogenic mosaic TP53 mutation in two germ layers detected by next generation sequencing. PLoS ONE 9, e96531 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrclinonc2014169_CR31","first-page":"11.1","volume":"11","author":"LD Stein","year":"2011","unstructured":"Stein, L. D. An introduction to the informatics of \u201cnext-generation\u201d sequencing. Curr. Protoc. Bioinformatics 11, 11.1 (2011).","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"BFnrclinonc2014169_CR32","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nrg3357","volume":"13","author":"LG Biesecker","year":"2012","unstructured":"Biesecker, L. G., Burke, W., Kohane, I., Plon, S. E. & Zimmern, R. Next-generation sequencing in the clinic: are we ready? Nat. Rev. Genet. 13, 818\u2013824 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"BFnrclinonc2014169_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/pbc.23283","volume":"58","author":"S Knapke","year":"2012","unstructured":"Knapke, S., Nagarajan, R., Correll, J., Kent, D. & Burns, K. Hereditary cancer risk assessment in a pediatric oncology follow-up clinic. Pediatr. Blood Cancer 58, 85\u201389 (2012).","journal-title":"Pediatr. Blood Cancer"},{"key":"BFnrclinonc2014169_CR34","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/gim.2013.201","volume":"16","author":"CV Fernandez","year":"2014","unstructured":"Fernandez, C. V.  et al. Attitudes of parents to the return of targeted and incidental genomic research findings in children. Genet. Med. 16, 633\u2013640 (2014).","journal-title":"Genet. Med."},{"key":"BFnrclinonc2014169_CR35","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/gim.2012.176","volume":"15","author":"LF Ross","year":"2013","unstructured":"Ross, L. F., Saal, H. M., David, K. L., Anderson, R. R. & American Academy of Pediatrics; American College of Medical Genetics and Genomics. Technical report: ethical and policy issues in genetic testing and screening of children. Genet. Med. 15, 234\u2013245 (2013).","journal-title":"Genet. Med."},{"key":"BFnrclinonc2014169_CR36","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1161\/CIRCGENETICS.110.958827","volume":"3","author":"RB Fabsitz","year":"2010","unstructured":"Fabsitz, R. B.  et al. Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ. Cardiovasc. Genet. 3, 574\u2013580 (2010).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"BFnrclinonc2014169_CR37","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1146\/annurev-genom-091212-153506","volume":"14","author":"SM Wolf","year":"2013","unstructured":"Wolf, S. M. Return of individual research results and incidental findings: facing the challenges of translational science. Annu. Rev. Genomics Hum. Genet. 14, 557\u2013577 (2013).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"BFnrclinonc2014169_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/gim.2013.73","volume":"15","author":"RC Green","year":"2013","unstructured":"Green, R. C.  et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 15, 565\u2013574 (2013).","journal-title":"Genet Med."},{"key":"BFnrclinonc2014169_CR39","unstructured":"American College of Medical Genetics and Genomics. ACMG Updates Recommendation on \u201cOpt Out\u201d for Genome Sequencing Return of Results \n                    [online]\n                    \n                  , (2014)."},{"key":"BFnrclinonc2014169_CR40","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1126\/science.1240156","volume":"340","author":"AL McGuire","year":"2013","unstructured":"McGuire, A. L.  et al. Point\u2013counterpoint. Ethics and genomic incidental findings. Science 340, 1047\u20131048 (2013).","journal-title":"Science"},{"key":"BFnrclinonc2014169_CR41","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/gim.2013.190","volume":"16","author":"IA Holm","year":"2014","unstructured":"Holm, I. A.  et al. Guidelines for return of research results from pediatric genomic studies: deliberations of the Boston Children's Hospital Gene Partnership Informed Cohort Oversight Board. Genet. Med. 16, 547\u2013552 (2014).","journal-title":"Genet. Med."},{"key":"BFnrclinonc2014169_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/15265161.2013.879945","volume":"14","author":"EW Clayton","year":"2014","unstructured":"Clayton, E. W.  et al. Addressing the ethical challenges in genetic testing and sequencing of children. Am. J. Bioeth. 14, 3\u20139 (2014).","journal-title":"Am. J. Bioeth."},{"key":"BFnrclinonc2014169_CR43","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/jlme.12135","volume":"42","author":"L Eckstein","year":"2014","unstructured":"Eckstein, L., Garrett, J. R. & Berkman, B. E. A framework for analyzing the ethics of disclosing genetic research findings. J. Law Med. Ethics 42, 190\u2013207 (2014).","journal-title":"J. Law Med. Ethics"},{"key":"BFnrclinonc2014169_CR44","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1038\/gim.2012.183","volume":"15","author":"CV Fernandez","year":"2013","unstructured":"Fernandez, C. V.  et al. Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research setting. Genet. Med. 15, 2558\u20132564 (2013).","journal-title":"Genet. Med."},{"key":"BFnrclinonc2014169_CR45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2350-11-4","volume":"11","author":"A Rasmussen","year":"2010","unstructured":"Rasmussen, A.  et al. Uptake of genetic testing and long-term surveillance in von Hippel\u2013Lindau disease. BMC Med. Genet. 11, 4 (2010).","journal-title":"BMC Med. Genet."},{"key":"BFnrclinonc2014169_CR46","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/bjs.9316","volume":"100","author":"P Barrow","year":"2013","unstructured":"Barrow, P., Khan, M., Lalloo, F., Evans, D. G. & Hill, J. Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome. Br. J. Surg. 100, 1719\u20131731 (2013).","journal-title":"Br. J. Surg."},{"key":"BFnrclinonc2014169_CR47","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi, M. L.  et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J. Clin. Endocrinol. Metab. 86, 5658\u20135671 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrclinonc2014169_CR48","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1158\/1055-9965.EPI-13-1069","volume":"23","author":"MA Ramirez-Ortiz","year":"2014","unstructured":"Ramirez-Ortiz, M. A.  et al. Diagnostic delay and sociodemographic predictors of stage at diagnosis and mortality in unilateral and bilateral retinoblastoma. Cancer Epidemiol. Biomarkers Prev. 23, 784\u2013792 (2014).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"BFnrclinonc2014169_CR49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jpedsurg.2012.10.012","volume":"48","author":"D Green","year":"2013","unstructured":"Green, D. The evolution of treatment of Wilms tumor. J. Pediatr. Surg. 48, 14\u201319 (2013).","journal-title":"J. Pediatr. Surg."},{"key":"BFnrclinonc2014169_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3322\/caac.21219","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward, E., DeSantis, C., Robbins, A., Kohler, B. & Jemal, A. Childhood and adolescent cancer statistics, 2014. CA Cancer J. Clin. 64, 83\u2013103 (2014).","journal-title":"CA Cancer J. Clin."},{"key":"BFnrclinonc2014169_CR51","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1470-2045(11)70119-X","volume":"12","author":"A Villani","year":"2011","unstructured":"Villani, A.  et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li\u2013Fraumeni syndrome: a prospective observational study. Lancet Oncol. 12, 559\u2013567 (2011).","journal-title":"Lancet Oncol."},{"key":"BFnrclinonc2014169_CR52","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1200\/JCO.2006.06.8213","volume":"25","author":"A Broniscer","year":"2007","unstructured":"Broniscer, A.  et al. Clinial and molecular characteristics of malignant transformation of low-grade glioma in children. J. Clin. Oncol. 25, 682\u2013689 (2007).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2014169_CR53","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10689-013-9639-6","volume":"13","author":"KW Jasperson","year":"2014","unstructured":"Jasperson, K. W.  et al. Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families. Fam. Cancer 13, 257\u2013265 (2014).","journal-title":"Fam. Cancer"},{"key":"BFnrclinonc2014169_CR54","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/(SICI)1096-911X(199903)32:3<196::AID-MPO6>3.0.CO;2-9","volume":"32","author":"PL Choyke","year":"1999","unstructured":"Choyke, P. L., Siegel, M. J., Craft, A. W., Green, D. M. & DeBaun, M. R. Screening for Wilms tumor in children with Beckwith\u2013Wiedemann syndrome or idiopathic hemihypertrophy. Med. Pediatr. Oncol. 32, 196\u2013200 (1999).","journal-title":"Med. Pediatr. Oncol."},{"key":"BFnrclinonc2014169_CR55","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10689-010-9368-z","volume":"9","author":"CR Lammens","year":"2010","unstructured":"Lammens, C. R.  et al. Regular surveillance for Li\u2013Fraumeni syndrome: advice, adherence and perceived benefits. Fam. Cancer 9, 647\u2013654 (2010).","journal-title":"Fam. Cancer"},{"key":"BFnrclinonc2014169_CR56","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/eye.2011.198","volume":"25","author":"PR Rothschild","year":"2011","unstructured":"Rothschild, P. R.  et al. Familial retinoblastoma: fundus screening schedule impact and guideline proposal. A retrospective study. Eye (Lond.) 25, 1555\u20131561 (2011).","journal-title":"Eye (Lond.)"},{"key":"BFnrclinonc2014169_CR57","doi-asserted-by":"crossref","unstructured":"Canadian Retinoblastoma Society. National Retinoblastoma Strategy Canadian Guidelines for Care: strat\u00e9gie th\u00e9rapeutique du r\u00e9tinoblastome guide clinique canadien. Can. J. Ophthalmol. 44 (Suppl. 2), S1\u2013S88 (2009).","DOI":"10.1016\/S0008-4182(09)80180-4"},{"key":"BFnrclinonc2014169_CR58","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1136\/bjo.2005.089375","volume":"90","author":"SM Imhof","year":"2006","unstructured":"Imhof, S. M., Moll, A. C., Schouten-van Meeteren, A. Y. Stage of presentation and visual outcome of patients screened for familial retinoblastoma: nationwide registration in the Netherlands. Br. J. Ophthalmol. 90, 875\u2013878 (2006).","journal-title":"Br. J. Ophthalmol."},{"key":"BFnrclinonc2014169_CR59","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/gut.2009.179804","volume":"59","author":"SR Cairns","year":"2010","unstructured":"Cairns, S. R.  et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 59, 666\u2013689 (2010).","journal-title":"Gut"},{"key":"BFnrclinonc2014169_CR60","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1440-1754.2006.00908.x","volume":"42","author":"TY Tan","year":"2006","unstructured":"Tan, T. Y. & Amor, D. J. Tumour surveillance in Beckwith\u2013Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice. J. Paediatr. Child Health 42, 486\u2013490 (2006).","journal-title":"J. Paediatr. Child Health"},{"key":"BFnrclinonc2014169_CR61","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mpo.1209","volume":"37","author":"DE McNeil","year":"2001","unstructured":"McNeil, D. E., Brown, M., Ching, A. & DeBaun, M. R. Screening for Wilms tumor and hepatoblastoma in children with Beckwith\u2013Wiedemann syndromes: a cost-effective model. Med. Pediatr. Oncol. 37, 349\u2013356 (2001).","journal-title":"Med. Pediatr. Oncol."},{"key":"BFnrclinonc2014169_CR62","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1067\/S0022-3476(03)00306-8","volume":"143","author":"CL Clericuzio","year":"2003","unstructured":"Clericuzio, C. L.  et al. Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith\u2013Wiedemann syndrome or isolated hemihyperplasia. J. Pediatr. 143, 270\u2013272 (2003).","journal-title":"J. Pediatr."},{"key":"BFnrclinonc2014169_CR63","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1399-0004.2009.01281.x","volume":"77","author":"ML Poulsen","year":"2010","unstructured":"Poulsen, M. L., Budtz-J\u00f8rgensen, E. & Bisgaard, M. L. Surveillance in von Hippel\u2013Lindau disease (vHL). Clin. Genet. 77, 49\u201359 (2010).","journal-title":"Clin. Genet."},{"key":"BFnrclinonc2014169_CR64","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ana.21107","volume":"61","author":"R Listernick","year":"2007","unstructured":"Listernick, R., Ferner, R. E., Liu, G. T. & Gutmann, D. H. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann. Neurol. 61, 189\u2013198 (2007).","journal-title":"Ann. Neurol."},{"key":"BFnrclinonc2014169_CR65","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/ajmg.a.34128","volume":"155A","author":"AF Bree","year":"2011","unstructured":"Bree, A. F., Shah, M. R. & BCNS Colloquium Group. Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS). Am. J. Med. Genet. A 155A, 2091\u20132097 (2011).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFnrclinonc2014169_CR66","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/02688690500081206","volume":"19","author":"DG Evans","year":"2005","unstructured":"Evans, D. G.  et al. Management of the patient and family with neurofibromatosis 2: a consensus conference statement. Br. J. Neurosurg. 19, 5\u201312 (2005).","journal-title":"Br. J. Neurosurg."},{"key":"BFnrclinonc2014169_CR67","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","volume":"49","author":"DA Krueger","year":"2013","unstructured":"Krueger, D. A., Northrup, H. & International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr. Neurol. 49, 255\u2013265 (2013).","journal-title":"Pediatr. Neurol."},{"key":"BFnrclinonc2014169_CR68","volume-title":"Malignant Rhabdoid Tumor Follow-up","author":"JI Geller","year":"2012","unstructured":"Geller, J. I., Leslie, N. D. & Yin, H. Malignant Rhabdoid Tumor Follow-up \n                    [online]\n                    \n                  , (2012)."},{"key":"BFnrclinonc2014169_CR69","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/pbc.25092","volume":"61","author":"KA Schultz","year":"2014","unstructured":"Schultz, K. A.  et al. Judicious DICER1 testing and surveillance imaging facilitates early diagnosis and cure of pleuropulmonary blastoma. Pediatr. Blood Cancer 61, 1695\u20131697 (2014).","journal-title":"Pediatr. Blood Cancer"},{"key":"BFnrclinonc2014169_CR70","volume-title":"GeneReviews\u00ae","author":"L Doros","year":"2014","unstructured":"Doros, L.  et al. DICER1-realted disorders (eds Pagon, R. A.  et al.) in GeneReviews\u00ae [internet] (University of Washington; 2014)."}],"container-title":["Nature Reviews Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2014.169","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2014.169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2014.169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:25:44Z","timestamp":1684466744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrclinonc.2014.169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,14]]},"references-count":70,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["BFnrclinonc2014169"],"URL":"https:\/\/doi.org\/10.1038\/nrclinonc.2014.169","relation":{},"ISSN":["1759-4774","1759-4782"],"issn-type":[{"value":"1759-4774","type":"print"},{"value":"1759-4782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,14]]},"assertion":[{"value":"14 October 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}